Table 2.
Validation patient cohort
| Group | n | Age (range) | Gender (M:F) |
|---|---|---|---|
| sALS | 23 | 66 (39–88) | 13:10 |
| Control | 22 | 62 (41–79) | 11:11 |
Key: sALS, sporadic amyotrophic lateral sclerosis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.